We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Near-Infrared Imaging Pinpoints Brain Tumors for Surgeons

By HospiMedica staff writers
Posted on 13 Apr 2004
"Night vision” goggles and beams of near-infrared (NIR) light may be able to detect tiny tumors and areas of cancerous tissue in the brain that surgeons can't normally see.

Researchers at the University of Texas M.D. More...
Anderson Cancer Center (Dallas, USA) have developed a special kind of dye that can find its way to tumors inoculated in the brain. They choose a dye from an in vivo screening process that binds to many human tumors as well as gliomas, but not to normal tissue. Then, using a NIR camera developed by scientists at Texas A& M University (College Station, USA), they tested the ability of the dye to pick up tumors as they grew in laboratory mice. Light in the NIR wavelength spectrum easily penetrated the skulls of the animals to "excite” the dye, and the emitted fluorescent signal was then captured by a CCD (charged couple device) camera. The tumors shone with a brighter light than the normal brain tissue around them.

"No one can determine tumor margins in brain tissue adequately right now, but our hope is that the emerging technology of near-infrared fluorescence optical imaging will provide this crucial information in real time to surgeons, as an operation is under way,” said Shi Ke, M.D., an instructor in the department of experimental diagnostic imaging at M.D. Anderson.

Although neurosurgeons now use diagnostic scans to pinpoint where tumors are located prior to an operation, once the skull is open, soft brain matter can shift, making it difficult to know where tumor tissue ends.





Related Links:
M.D. Anderson
Texas A&M

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.